Abstract
The search for a specific, clinically useful treatment to arrest or reverse the autodigestive process believed to be the central pathophysiologic event in acute pancreatitis has so far been frustrating and unsuccessful. One major approach to this problem has been the use of agents such as anticholinergic drugs, glucagon, calcitonin, and somatostatin which have been shown in physiological studies to inhibit pancreatic exocrine secretion. Unfortunately, none of these substances proved to be of value in prospective, randomized clinical trials [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Steinberg WM, Schlesselmann SE (1987) Treatment of acute pancreatitis. Gastroenterology 93:1420–1427
Zucker KA, Adrian TE, Modlin IM (1988) Cholecystokinin receptor antagonists. J Surg Res 45:496–504
Evander A, Lundquist I, Ihse I (1982) Influence of gastrointestinal hormones on the course of acute experimental pancreatitis. Hepatogastroenterology 29: 161–166
Lample M, Kern HF (1977) Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secratogogue. Virchows Arch [A] 373:97–117
Niederau C, Ferrell LD, Grendell JH (1985) Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology 88:1192–1204
Saluja AK, Saluja M, Printz H, Zavertnik A, Sengupta A, Steer ML (1989) Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Proc Natl Acad Sci USA 86:8968–8971
Otsuki M, Tani S, Okabayashi Y, Nakamura T, Fujii M, Fujisawa T, Baba S, Itoh H (1989) Effect of a new cholecystokinin receptor antagonist CR 1392 on caerulein-induced acute pancreatitis in rats. Pancreas 4:237–243
Niederau C, Liddle RA, Ferrell LD, Grendell JH (1986) Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. J Clin Invest 78:1056–1063
McQuaid KR, Niederau C, Ferrell LD, Grendell JH (1988) Effects of chlorglumide alone or with atropine or gastrin on diet-induced acute hemorrhagic pancreatitis in mice (Abstr). Pancreas 3:607
Oshio G, Saluja A, Leli U, Sengupta A, Steer ML (1989) Failure of a potent cholecystokinin antagonist to protect against diet-induced pancreatitis in mice. Pancreas 6:739–743
Silverman M, Hardi C, Bank S, Kranz V, Lendvai S (1989) Effects of the cholecystokinin antagonist L-364718 on experimental pancreatitis in mice. Gastroenterology 96:186–192
Gomez G, Townsend CM Jr, Green DW, Rajaraman S, Uchida T, Greeley GH Jr, Soloway RD, Thompson JC (1990) Protective action of luminal bile salts in necrotizing acute pancreatitis in mice. J Clin Invest 86:323–331
Yu D-H, Huang SC, Wank SA, Mantey S, Gardner JD, Jensen RT (1990) Pancreatic receptors for cholecystokinin: evidence for three receptor classes. Am J Physiol 258:G86–G95
Modlin IM, Bilchik AJ, Zucker KA, Adrian TE, Sussman J, Graham SM (1989) Cholecystokinin augmentation of ‘‘surgical” pancreatitis. Benefits of receptor blockade. Arch Surg 124:574–578
Wisner JR Jr, Renner IG (1988) Asperlicin, a nonpeptidal cholecystokinin antagonist, attenuates sodium taurocholate-induced acute pancreatitis in rats. Pancreas 3:174–179
Makovec F, Bani M, Cereda R, Chiste R, Revel L, Rovati LC, Setnikar I, Rovati LA (1986) Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and mice. Peptides 7:1159–1164
Tani S, Okabayashi Y, Nakamura T, Fujii M, Itoh H, Otsuki M (1990) Effect of a new cholecystokinin receptor antagonist loxiglumide on acute pancreatitis in two experimental animal models. Pancreas 5:284–290
Mitchell CJ, Playforth MJ, Kelleher J, McMahon MJ (1983) Functional recovery of the exocrine pancreas after acute pancreatitis. Scand J Gastroenterol 18:5–8
Niederau C, Niederau M, Lüthen R, Strohmeyer G, Ferrell LD, Grendell JH (1990) Pancreatic exocrine secretion in acute experimental models. Gastroenterology 99:1120–1127
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Grendell, J.H. (1991). Experimental Pancreatitis. In: Adler, G., Beglinger, C. (eds) Cholecystokinin Antagonists in Gastroenterology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76362-5_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-76362-5_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76364-9
Online ISBN: 978-3-642-76362-5
eBook Packages: Springer Book Archive